CAS 3916-18-5 appears in our catalog under these names: H-DL-beta-(3,4-Dihydroxyphenyl)-DL-Ser-OH, Droxidopa Impurity 10 (DL-threo-Droxidopa), Droxidopa Impurity 4, DL-threo-Droxidopa, >95% (HPLC). Offered by: Creative Peptides, Chemat Brand, Hubei YoungXin, TRC. Available pack sizes: 50mg, 250mg, 1g, on request, 10mg, 25mg, 100mg, 200mg.
Droxidopa is a serine derivative that is L-serine substituted at the beta-position by a 3,4-dihydroxyphenyl group. A prodrug for noradrenalone, it is used for treatment of neurogenic orthostatic hypotension. It has a role as an antihypertensive agent, a prodrug and a vasoconstrictor agent. It is a L-tyrosine derivative and a member of catechols.
Source: ChEBI
| Molecular formula | C9H11NO5 |
|---|---|
| Molecular weight | 213.19 g/mol |
| IUPAC name | (2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid |
| InChIKey | QXWYKJLNLSIPIN-JGVFFNPUSA-N |
| SMILES | C1=CC(=C(C=C1[C@H]([C@@H](C(=O)O)N)O)O)O |
Computed by PubChem (NCBI)